HomepageMedicineAstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis Medicine AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis admin Posted on May 8, 2024 Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostMore ghost malls in the making as consumers shun poorly managed shopping centres Next PostHow Much Money Did This Year’s Met Gala Raise? You Might Also Like Medicine Mirikizumab Demonstrates Superiority to Ustekinumab in Treating Crohn Disease admin October 17, 2024 Medicine FDA Grants Accelerated Approval to Brukinsa Plus Gazyva for Relapsed or Refractory Follicular Lymphoma admin March 8, 2024 Medicine How to Rally a Team Around Building a New Business admin October 11, 2024 Medicine FDA Approves AstraZeneca, Daiichi Sankyo’s Datroway for Previously Untreated Unresectable, Metastatic HR-Positive, HER2-Negative Breast Cancer admin January 21, 2025
Medicine Mirikizumab Demonstrates Superiority to Ustekinumab in Treating Crohn Disease admin October 17, 2024
Medicine FDA Grants Accelerated Approval to Brukinsa Plus Gazyva for Relapsed or Refractory Follicular Lymphoma admin March 8, 2024
Medicine FDA Approves AstraZeneca, Daiichi Sankyo’s Datroway for Previously Untreated Unresectable, Metastatic HR-Positive, HER2-Negative Breast Cancer admin January 21, 2025